ARCHIVES

In Brief: Hellman To Head DCT board; Gard Joins Colorado Group; NCI May Support Death Index

This article is from The Cancer Letter archive.

Vol. 06 No. 36 | September 12, 1980

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000

National Action Plan Issues Complete List Of Breast Cancer Funding Mechanisms

May 26, 1995

White House Preparing To Nominate Andrew von Eschenbach as FDA Commissioner, Sources Said

March 3, 2006